The ASX blockchain-based replacement for its clearing and settlement system CHESS has been delayed yet again this week for the fourth time. The major project undertaken by the ASX five years ago is still showing no signs of completion. Followed by delay after delay – it appears that this is one of the longest and
Read More
A shrinking global labour pool will demand better wages and conditions, pushing up prices. This month I want to address a common question being asked by investors i.e. ‘how long could high and higher prices last’. The short answer is that a very, very long time. But there may be a silver lining here. Over the
Read More
Rhythm Biosciences (ASX: RHY) is a step closer to commercialising their bowel cancer detection test, having submitted documents to the Australian Therapeutic Goods Administration (TGA) for approval. The filing is a significant milestone for the Company who are hoping to launch their product to market later this year. Rhythm’s test offers a convenient and non-invasive
Read More
The opioid epidemic has been an issue for years now. Since 1990 over half a million deaths have been attributed to opioid overdose. Primarily mediatised as an ‘American’ problem, opioid misuse is significant in most developed countries. Most people begin their dependence on opioids following surgery where the drugs are prescribed as a method of
Read More
When it comes to offshore services, time spent at dock is time wasted but comfortably on top of that, MMA Offshore (ASX: MRM) is set to deploy MMA Pinnacle to Qatar within just weeks of finishing another 3-year offshore contract. The new deal is valued at $23 million with MMA to provide offshore construction support
Read More